South Korea Interventional Oncology Market Size, Share, and COVID-19 Impact Analysis, By Technique (Ablation Therapies and Embolization Therapies), By Procedure (Tumor Ablation and Tumor Biopsy), By Applications (Liver Cancer), and South Korea Interventional Oncology Market Insights, Industry Trend, Forecasts to 2035

South Korea Interventional Oncology Market Insights Forecasts to 2035

• The South Korea Interventional Oncology Market Size Was Estimated at USD 47.9 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 10.05% from 2025 to 2035
• The South Korea Interventional Oncology Market Size is Expected to Reach USD 137.4 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The South Korea Interventional Oncology Market Size is anticipated to Reach USD 137.4 Million by 2035, Growing at a CAGR of 10.05% from 2025 to 2035.  The increased incidence of cancer, the development of minimally invasive techniques, the aging of the population, the emphasis on early cancer detection, and the rise in both public and private funding for interventional oncology.

Market Overview

A subspecialty of interventional radiology called interventional oncology (IO) is dedicated to the diagnosis and treatment of cancer with image-guided, minimally invasive techniques.  It entails directing targeted treatments straight to tumors utilizing cutting-edge medical imaging techniques like MRI, CT, ultrasound, and X-rays.  Compared to standard surgery, this method seeks to enhance patient outcomes by reducing recovery durations, pain, and complication rates.  Using imaging guidance (CT, MRI, ultrasound), interventional oncology employs methods such as ablation, embolization, and percutaneous biopsy to directly target malignancies. This method reduces harm to the surrounding healthy tissue, which lessens the patients pain and discomfort. Compared to standard surgery, interventional oncology techniques such as thermal ablation, transarterial chemoembolization (TACE), and selective internal radiation treatment (SIRT) offer fewer problems and faster recovery periods.  As a crucial part of comprehensive cancer care strategies, which include early detection, diagnosis, and treatment, cancer control programs often include interventional oncology.

Report Coverage

This research report categorizes the market for South Korea interventional oncology market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea interventional oncology market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea interventional oncology market.

Driving Factors

Rising cancer incidence from liver to lung cancers is driving demand for precise, minimally invasive therapies that offer faster recovery and less pain. Technological innovations in imaging (CT, MRI, ultrasound), catheter-based delivery, AI-enhanced planning, and robotic systems are improving treatment accuracy and adoption. Cost-efficiency and shorter hospital stays promote outpatient care and appeal to patients and payers. Additionally, personalized medicine trends support targeted tumor treatments over systemic approaches

Restraining Factors

High equipment and procedure costs including advanced imaging systems, single use devices, specialized catheters, and embolic agents limit adoption, especially in low and middle income regions. Infrastructure demands and expensive capital investments burden hospitals lacking financial resources. A shortage of trained interventional radiologists, oncologists, and multidisciplinary teams impedes procedure availability and geographical expansion.

Market Segmentation

The South Korea interventional oncology market share is classified into technique, procedure, and application.

• The ablation therapies segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea interventional oncology market is segmented by technique into ablation therapies and embolization therapies. Among these, the ablation therapies segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. They are less intrusive and effectively target tumors with little harm to adjacent tissues. Ablation therapies such as radiofrequency, microwave, cryoablation, and laser ablation are becoming more and more popular.  With shorter recovery periods, less discomfort, and fewer side effects, these medicines present a possible substitute for conventional cancer treatments like radiation and surgery.

• The tumor ablation segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea interventional oncology market is segmented by procedure into tumor ablation and tumor biopsy. Among these, the tumor ablation segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The market for interventional oncology, tumor ablation procedures such as radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, and laser ablation are a rapidly growing segment.

• The liver cancer segment dominated share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea interventional oncology market is segmented by application into liver cancer. Among these, the liver cancer segment dominated share in 2024 and is expected to grow at a significant CAGR during the forecast period. Several important variables, the liver cancer sector accounts for the biggest share of the interventional oncology market. Hepatocellular carcinoma (HCC), in particular, is one of the most prevalent and fatal types of liver cancer.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea interventional oncology market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Terumo International Systems
• BTG International Medicine (Korea)
• GE Heathcare Korea (International Radiology & Oncology)
• Elekta Korea
• Oncology Imaging Systems Korea Company
• INFINITY Healthcare
• RF Medical Co.Ltd
• Taewoong Medical Co. Ltd
• GC Pharma (Green Cross Coporation)
• Samsung Biologics
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea interventional oncology market based on the below-mentioned segments:

South Korea Interventional Oncology Market, By Technique

• Ablation Therapies
• Embolization Therapies

South Korea Interventional Oncology Market, By Procedure

• Tumor Ablation
• Tumor Biopsy

South Korea Interventional Oncology Market, By Application

• Liver Cancer